| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_451758c05b923e919f4993d1e9bf1d04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f97986c94313b4cf4d66c26670f78f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f6be7b5f316f050e9151b3afd8936f7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2013-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6e601c32c8d22e273f94ed2fff6f5b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76c2d778d37eddc36d5325f6727e25c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8653275d0e0f58bb81480db56d97a473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b71035b06bc96a032b204a50b94a3a8f |
| publicationDate |
2015-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-105073197-A |
| titleOfInvention |
Combination of Anti-CD20 Antibody and PI3 Kinase Selective Inhibitor |
| abstract |
Provided herein are highly potent combinations of compounds of formula A (PI3Kδ selective inhibitors) with anti-CD20 antibodies for the treatment and amelioration of PI3Kδ and/or CD20 mediated diseases and disorders. In particular, the combination can be used in the treatment of cancer and autoimmune diseases. More particularly, the present invention provides a combination of a compound of formula A or a stereoisomer thereof and ublituximab for treating and/or improving hematological malignancies such as leukemia and lymphoma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021164789-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110191720-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109640964-A |
| priorityDate |
2012-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |